Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Swedish technology trading group Addtech AB acquires Danish components supplier Chemo Electric A/S
- NORDIC BUSINESS REPORT-26 June 2007-Swedish technology trading group Addtech AB acquires Danish components supplier Chemo Electric A/SC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com Swedish technology trading group Addtech AB said on Monday (25 June) that its subsidiary Addtech Components has agreed to acquire the Danish components supplier Chemo Electric A/S from...
- Research articles 2007-06-26
- Health Insurers Canceling Policies Without Warning
- Some patients with serious illnesses have discovered their insurance companies are dropping them and charging them for treatment after the fact. Sandra Hughes reports on this alarming trend.
- Videos 2009-05-10
Additional Resources
- Yale Researchers to Present Data at AACR Conference Indicating That Novogen Compound NV-128 Uses mTOR Pathway to Induce Cell Death in Chemo-Resistant Ovarian Cancer Cells
- An abstract for an oral presentation to be given at the Annual Meeting of the American Association for Cancer Research, April 12 - 16, in San Diego, Calif., is now available (abstract number 4926) at www.aacr.org . The abstract, describing work undertaken by Professor Gil Mor and colleagues...
- Research articles 2008-03-25
- Chemo-resistant ovarian cancer cells can be destroyed, Yale researchers report.
- M2 PRESSWIRE-1 April 2003-YALE UNIVERSITY: Chemo-resistant ovarian cancer cells can be destroyed, Yale researchers reportC1994-2003 M2 COMMUNICATIONS LTD RDATE:03292003 New Haven, Conn. -- Yale School of Medicine researchers today released laboratory based data identifying significant new signaling pathways for ovarian...
- Research articles 2003-04-01
- Chemo raises heart risks?
- WASHINGTON -- Breast cancer survivors may face increased risk of heart disease -- and doctors are debating if it's time to largely abandon a chemotherapy mainstay that is one reason for the problem. Drugs called anthracyclines are a breast chemo staple despite a well-known risk: They weaken some...
- Research articles 2007-10-09
- Gene Thought to Assist Chemo May Help Cancer Thrive
- To: HEALTH/MEDICAL EDITORSContact: David Terraso of Georgia Institute of Technology, +1-404- 385-2966, David.Terraso@icpa.gatech.edu ATLANTA, May 18 /PRNewswire-USNewswire/ -- A gene thought to be essential in helping chemotherapy kill cancer cells may actually help them thrive. In a new study of chemo patients, scientists at the Georgia Institute of Technology and...
- Research articles 2007-05-18
- Genmab Initiates Combination Study of HuMax-EGFr With Chemo-Radiation.
- COPENHAGEN, Denmark, October 24 /PRNewswire/ -- - Study Focuses on First Line Treatment of Head and Neck Cancer Genmab A/S (CSE: GEN) announced today it has initiated a Phase I/II study of HuMax-EGFrTM zalutumumab in combination with chemo-radiation as first line treatment...
- Research articles 2006-10-24
- ImClone Systems Inc. Q3 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator [Operator Instructions]. Your first question comes from May-Kin Ho of Goldman Sachs. May-Kin Ho - Goldman Sachs Hi. I guess, I wanted to ask question about really how your payment from Bristol would be recognized and how we should going forward project out...
- Earnings calls 2007-10-25
- The chemical officer in the digitized artillery battalion - From the Field
- Digitization did not change the role of the chemical officer ChemO in the digitized artillery battalion. It enhanced the ability of the ChemO to plan and conduct nuclear, biological, and chemical NBC operations. Although many pieces of equipment were not designed with the ChemO in mind, most of the Army...
- Research articles 2002-07-01
- Alfacell Corporation F3Q08 (Qtr End 04/30/2008) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions Your first question comes from Stephen Dunn - Dawson James. Stephen Dunn - Dawson James Do you have your results of 122 patients? Do you have a hypothesis of the mechanism of actions for ONCONASE and why it would work...
- Earnings calls 2008-06-11
- Chemotherapy can sometimes leave you in a fog.(Health & Fitness)(Life with cancer)
- Byline: Ruth Gesmer Silverman It's become trendy to be living with cancer. Tony Snow just returned to work at the White House. Elizabeth Edwards is back on the campaign trail. I wake up in the middle of the night with new ideas...
- Research articles 2007-05-07
- Physically Synthesized Ni-Cu Nanoparticles for Magnetic Hyperthermia
- This paper presents a physical method to prepare copper-nickel alloy particles in the submicron range for possible self controlled magnetic hyperthermia treatment of cancer is described. It reports that an increase in tumor temperature decreases the tumor resistance to chemo and radiation therapies. Self controlled heating at the tumor site...
- White papers 2004-05-08
- Modeling and Simulation of the Swelling Behavior of pH-Stimulus-Responsive Hydrogels
- The modulation of the swelling ability of the hydrogel matrix by pH-stimulus enables the dynamic control of the swelling forces, thereby obtaining effective diffusivity and permeability of the solutes, or mechanical energy from the hydrogel. In this work, a chemo-electro-mechanical model describing hydrogel behavior, based on multi-field effects, is developed...
- White papers 2004-10-29
- Biotech's New Blockbusters -- Oh, Really?
- Biotech's New Blockbusters -- Oh, Really?20 to 30 Blockbusters of Biotech Exist NowInnovation in Pharmacology?Beginning in the 1970, biopharmaceuticals were being researched for conceptual production in those places once called academic institutions. The first biopharmaceutical ever was a synthetic insulin called Humulin made by Genetech in 1982. Later...
- Discussion threads 2008-07-10
- ADVISORY/ Spotfire to Present At IBC's Chemo Bioinformatics Conference
- Business/Technology Editors
- Research articles 2001-02-13
- MIT Team Aims To Reduce Chemo Doses.
- Byline: MIT Byline: MIT
- Research articles 2005-01-06
- CELGENE CORPORATION.
- CELGENE CORPORATION and the National Cancer Institute NCI are collaborating on a pilot trial in which patients with advanced non-small cell lung cancer will ... CELGENE CORPORATION and the National Cancer Institute NCI are collaborating on a pilot trial in which patients with advanced...
- Research articles 1999-03-29
- Hana Biosciences Initiates Pivotal Trials of Zensana™, First Ondansetron Oral Spray in Chemo-Induced Nausea and Vomiting
- SOUTH SAN FRANCISCO, Calif. -- Hana Biosciences (AMEX:HBX):
- Research articles 2005-12-12
- CytoGenix Inc. Invents Revolutionary Large-Scale Manufacturing Process for High-Purity DNA
- HOUSTON -- CytoGenix Inc. (OTCBB:CYGX) announces the filing of a patent application with the US Patent and Trademark Office for an invention titled "Chemo-Enzymatic Synthesis of DNA and Uses Thereof." This new technology is a significant advance and a big step towards making DNA medicines a reality. The limited supply...
- Research articles 2004-12-14
- Roche Chemo Drug Approved in China for Gastric Cancer
- ChinaBio Today submits: Roche (RHHBY.PK) announced that Xeloda, an oral chemotherapy drug, was granted SFDA approval for an additional indication: gastric cancer. Xeloda, which is inactive in pill form, becomes active when it comes into contact with a naturally occurring protein called thymidine phosphorylase [TP]. TP transforms the ingredients...
- External links 2008-09-03
- << Previous
- page 1 of 1
- Next >>
